comparemela.com

Latest Breaking News On - Bacterial vaginosis - Page 18 : comparemela.com

Potential Modification of Vaginal Microbiome Might Prevent Sexually Transmitted Diseases and Premature Birth

Scientists have examined potential approaches against bacterial vaginosis in the female genital tract.

United statesSandy huffakerCenters for diseaseHarvard universityMassachusetts institute of technologyGetty imagesSexually transmitted diseaseNature microbiologyMassachusetts instituteDisease controlDoctor slams miracleVaginal rejuvenation techniqueVaginal microbiomeSexually transmitted diseasePremature birthHuman immunodeficiency virus

Top February 2022 FDA Drug Approvals

February 2022 FDA drug approvals include treatments for bacterial vaginosis, COVID-19, spasticity, and cold agglutinin.

Eli lillyLupin pharmaceuticals incDrug administrationAzurity pharmaceuticalsBacterial vaginosisSpasticity dueEmergency use authorizationCold agglutinin

FDA Approves Secnidazole for BV, Trichomoniasis in Adolescents

The FDA has approved secnidazole for the treatment of bacterial vaginosis and trichomoniasis in patients aged 12 years and older.

United statesTom merriamDrug administrationLupin pharmaceuticalsSkin and soft tissue infectionSexually transmitted disease stdSexually transmitted diseaseSexually transmitted infectionTi sexually transmitted infectionUs food and drug administrationNited states food and drug administrationBacterial vaginitisBacterial vaginosisPelvic inflammatory disease pidPelvic inflammatory diseaseId pelvic inflammat

Lupin in promotional agreement with Exeltis for SOLOSEC

SOLOSEC is indicated for the treatment of Bacterial Vaginosis in adult women and Trichomoniasis in adults

Vinita guptaWomen healthLupin pharmaceuticalsExeltis united statesBacterial vaginosisHealthcare providers

Lupin Signs Promotional Agreement with Exeltis on SOLOSEC® (secnidazole) expanding access for Adult Women Suffering with Bacterial Vaginosis and Adults with Trichomoniasis

/PRNewswire/ Lupin Pharmaceuticals Inc., (Lupin), and Exeltis USA Inc. announced a promotional agreement for Exeltis to promote SOLOSEC® along with Exeltis .

United statesExeltis salustiano perezInsud pharmaVinita guptaShweta munjalLupin pharmaceuticals incExeltis united states incPrnewswire lupin pharmaceuticals incCorporate communicationsWomen healthLupin incPharmaceuticals incExeltis united statesBacterial vaginosisHealthcare providersChief executive officer

vimarsana © 2020. All Rights Reserved.